Advertisement
News
Advertisement

ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology

Fri, 03/04/2011 - 6:34am
Bio-Medicine.Org

CHICAGO, March 4, 2011 /PRNewswire/ -- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept for the use of magnetic particles for targeted cancer treatment, advanced sterilization techniques, an advanced imaging system, and an advanced microbolometer. These patents from Oxford Instruments not only address many current limitations, but do so in ways that dramatically increase performance.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

Key Features & Benefits

The four patent sets disclose the following:

Advanced Magnetic Therapies

Investigations of magnetic micro- and nanoparticles for targeted drug delivery began over 30 years ago. This is in particular important in cancer therapy where existing chemotherapeutic treatments may not be specific and have unwanted side effects.

  • The patents disclose advanced techniques for the use of magnetic particles for therapeutic applications to disrupt biological materials such as cancer cells and tumors. The particles may be targeted using suitable targeting moieties such as antibodies.
  • The treatment technique uses an anisotropic magnetic material that exhibits different properties in magnetic and non-magnetic states.
  • The material is delivered in a non-magnetic state and then switched to a magnetic state which is repeated multiple times.
  • It is proposed that the induced magnetic gyrations and rotations kill the cancerous cells/tissues without causing excessive damage to unaffected cells/tissues.
  • This lot should be of interest to me

    '/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading